Upstream deregulation of calcium signaling in Parkinson's disease

Frontiers in Molecular Neuroscience

Volumn 7, Issue JUNE, 2014, Pages

  Rivero Ríos, Pilar ^a   Gómez Suaga, Patricia ^a   Fdez, Elena ^a   Hilfiker, Sabine ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

Calcium; Dopamine; Endoplasmic reticulum; Golgi; Lysosomes; Mitochondria; Parkinson's disease

Indexed keywords

DOPAMINE; REACTIVE OXYGEN METABOLITE;

AGING; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL DEATH; CELL FUNCTION; DEREGULATION; DISEASE COURSE; GOLGI COMPLEX; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NERVE DEGENERATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PARKINSON DISEASE; PHENOTYPE; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; PROTEIN PROCESSING; RESPIRATORY CHAIN; RISK FACTOR;

EID: 84902576593     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2014.00053     Document Type: Article

References (117)

1. 2+)-ATPase on the lysosomal membrane and ecto-ATPase on the plasma membrane from rat liver. Biol. Pharm. Bull. 19, 1291-1297. doi: 10.1248/bpb.19.1291
2. Anglade, P., Vyas, S., Javoy-Agid, F., Herrero, M. T., Michel, P. P., Marquez, J., et al. (1997). Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12, 25-31.
3. Augustine, G. J., Santamaria, F., and Tanaka, K. (2003). Local calcium signaling in neurons. Neuron 40, 331-346. doi: 10.1016/S0896-6273(03)00639-1
4. Bauerfeind, R., Jelinek, R., Hellwig, A., and Huttner, W. B. (1995). Neurosecretory vesicles can be hybrids of synaptic vesicles and secretory granules. Proc. Natl. Acad. Sci. U.S.A. 92, 7342-7346. doi: 10.1073/pnas.92.16.7342
5. Becker, C., Jick, S. S., and Meier, C. R. (2008). Use of antihyperten-sives and the risk of Parkinson disease. Neurology 70, 1438-1444. doi: 10.1212/01.wnl.0000303818.38960.44
6. Beilina, A., Rudenko, I. N., Kaganovich, A., Civiero, L., Chau, H., Kalia, S. K., et al. (2014). Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease. Proc. Natl. Acad. Sci. U.S.A. 111, 2626-2631. doi: 10.1073/pnas.1318306111
7. Bender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., et al. (2006). High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat. Genet. 38, 515-517. doi: 10.1038/ng1769
8. Berridge, M. J. (2002). The endoplasmic reticulum: a multifunctional signaling organelle. Cell Calcium 32, 235-249. doi: 10.1016/S0143416002001823
9. Berridge, M. J., Lipp, P., and Bootman, M. D. (2000). The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1, 11-21. doi: 10.1038/35036035
10. Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., and Greenamyre, J. T. (2000). Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301-1306. doi: 10.1038/81834
11. Bezprozvanny, I. (2012). Presenilins: a novel link between intracellular calcium signaling and lysosomal function? J. Cell Biol. 198, 7-10. doi: 10.1083/jcb.201206003
12. Bonci, A., Grillner, P., Mercuri, N. B., and Bernardi, G. (1998). L-type calcium channels mediate a slow excitatory synaptic transmission in rat midbrain dopaminergic neurons. J. Neurosci. 18, 6693-6703.
13. Braak, H., Ghebremedhin, E., Rueb, U., Bratzke, H., and Del Tredici, K. (2004). Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 318, 121-134. doi: 10.1007/s00441-004-0956-9
14. Cali, T., Ottolini, D., and Brini, M. (2011). Mitochondria, calcium, and endo-plasmic reticulum stress in Parkinson's disease. Biofactors 37, 228-240. doi: 10.1002/biof.159
15. 2+ transfer to sustain cell bioenergetics. Biochim. Biophys. Acta 1832, 495-508. doi: 10.1016/j.bbadis.2013.01.004
16. + channels to adapt to metabolic state. Cell 152, 778-790. doi: 10.1016/j.cell.2013.01.023
17. Chan, C. S., Guzman, J. N., Ilijic, E., Mercer, J. N., Rick, C., Thatch, T., et al. (2007). 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature 447, 1081-1086. doi: 10.1038/nature05865
18. Cherra, S. J. III, Steer, E., Gusdon, A. M., Kiselyov, K., and Chu, C. T. (2013). Mutant LRRK2 elicits calcium imbalance and depletion of dendritic mitochondria in neurons. Am. J. Pathol. 182, 474-484. doi: 10.1016/j.ajpath.2012.10.027
19. 2+ diffusion. J. Neurosci. 26, 12137-12136. doi: 10.1523/JNEUROSCI.3158-06.2006
20. 2+ from reserve granules, lysosome-related organelles, in sea urchin eggs. Cell 111, 703-708. doi: 10.1016/S0092-8674(02)01082-6
21. Csordas, G., Renken, C., Varnai, P., Walter, L., Weaver, D., Buttle, K. F., et al. (2006). Structural and functional features and significance of the physical linkage between ER and mitochondria. J. Cell Biol. 174, 915-921. doi: 10.1083/jcb.200604016
22. Damier, P., Hirsch, E. C., Agid, Y., and Graybiel, A. M. (1999). The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122, 1437-1448. doi: 10.1093/brain/122.8.1437
23. 2+ in autophagy regulation. Cell Calcium 50, 242-250. doi: 10.1016/j.ceca.2011.04.001
24. Dehay, B., Martinez-Vicente, M., Caldwell, G. A., Caldwell, K. A., Yue, Z., Cookson, M. R., et al. (2013). Lysosomal impairment in Parkinson's disease. Mov. Disord. 28, 725-732. doi: 10.1002/mds.25462
25. de Lau, L. M., Giesbergen, P. C., de Rijk, M. C., Hofman, A., Koudstaal, P. J., and Breteler, M. M. (2004). Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 63, 1240-1244. doi: 10.1212/01.WNL.0000140706.52798.BE
26. de Rijk, M. C., Tzourio, C., Breteler, M., Dartigues, J. F., Amaducci, L., Lopez-Pousa, S., et al. (1997). Prevalence of parkinsonism in Parkinson's disease in Europe: the EUROPARKINSON collaborative study. European community concerted action on the epidemiology of Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 62, 10-15. doi: 10.1136/jnnp.62.1.10
27. Dodson, M. W., Zhang, T., Jiang, C., Chen, S., and Guo, M. (2012). Roles of the Drosophila LRRK2 homolog in rab7-dependent lysosomal positioning. Hum. Mol. Genet. 21, 1350-1363. doi: 10.1093/hmg/ddr573
28. Dryanovski, D. I., Guzman, J. N., Xie, Z., Galteri, D. J., Volpicelli-Daley, L. A., Lee, V. M., et al. (2013). Calcium entry and α-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons. J. Neurosci. 33, 10154-10164. doi: 10.1523/JNEUROSCI.5311-12.2013
29. Egan, M. E., Glockner-Pagel, J., Ambrose, C. A., Cahill, P. A., Pappoe, L., Balamuth, N., et al. (2002). Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells. Nat. Med. 8, 485-492. doi: 10.1038/nm0502-485
30. Egan, M. E., Pearson, M., Weiner, S. A., Rajendran, V., Rubin, D., Glöckner-Pagel, J., et al. (2004). Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 304, 600-602. doi: 10.1126/science.1093941
31. 2+)-ATPase in rat liver lysosomal membranes. J. Biochem. 112, 33-39.
32. Fan, J., Hu, Z., Zeng, L., Lu, W., Tang, X., Zhang, J., et al. (2008). Golgi apparatus and neurodegenerative diseases. Int. J. Dev. Neurosci. 26, 523-534. doi: 10.1016/j.ijdevneu.2008.05.006
33. Fahn, S. (2005). Does levodopa slow or hasten the rate of progression of Parkinson's disease? J. Neurol. 252(Suppl. 4), IV37-IV42. doi: 10.1007/s00415-005-4008-5
34. Fliegert, R., Gasser, A., and Guse, A. H. (2007). Regulation of calcium signalling by adenine-based second messengers. Biochem. Soc. Trans. 35, 109-114. doi: 10.1042/BST0350109
35. Foehring, R. C., Zhang, X. F., Lee, J. C., and Callaway, J. C. (2009). Endogenous calcium buffering capacity of substantia nigral dopamine neurons. J. Neurophysiol. 102, 2326-2333. doi: 10.1152/jn.00038.2009
36. Fujita, Y., Ohama, E., Takatama, M., Al-Sarraj, S., and Okamoto, K. (2006). Fragmentation of Golgi apparatus of nigral neurons with alpha-synuclein-positive inclusions in patients with Parkinson's disease. Acta Neuropathol. 112, 261-265. doi: 10.1007/s00401-006-0114-4
37. Gandhi, S., Wood-Kaczmar, A., Yao, Z., Plun-Favreau, H., Deas, E., Klupsch, K., et al. (2009). PINK1-associated Parkinson's disease is caused by neu-ronal vulnerability to calcium-induced cell death. Mol. Cell 33, 627-638. doi: 10.1016/j.molcel.2009.02.013
38. German, D. C., Manaye, K. F., Sonsalla, P. K., and Brooks, B. A. (1992). Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells. Ann. N.Y. Acad. Sci. 648, 42-62. doi: 10.1111/j.1749-6632.1992.tb24523.x
39. Goldberg, J. A., Guzman, J. N., Estep, C. M., Ilijic, E., Kondapalli, J., Sanchez-Padilla, J., et al. (2012). Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease. Nat. Neurosci. 15, 1414-1421. doi: 10.1038/nn.3209
40. Gómez-Suaga, P., Luzón-Toro, B., Churamani, D., Zhang, L., Bloor-Young, D., Patel, S., et al. (2012). Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP. Hum. Mol. Genet. 21, 511-525. doi: 10.1093/hmg/ddr481
41. Grace, A. A., and Bunney, B. S. (1983). Intracellular and extracellular elec-trophysiology of nigral dopaminergic neurons-2. Action potential generating mechanisms and morphological correlates. Neuroscience 10, 317-331. doi: 10.1016/0306-4522(83)90136-7
42. Greenamyre, J. T., and Hastings, T. G. (2004). Parkinson's-divergent causes, convergent mechanisms. Science 304, 1120-1122. doi: 10.1126/science.1098966
43. Guerreiro, S., Toulorge, D., Hirsch, E., Marien, M., Sokoloff, P., and Michel, P. P. (2008). Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels. Mol. Pharmacol. 74, 980-989. doi: 10.1124/mol.108.048207
44. 2+ trigger. Sci. Signal. 1:re10. doi: 10.1126/scisignal.144re10
45. Guzman, J. N., Sanchez-Padilla, J., Chan, C. S., and Surmeier, D. J. (2009). Robust pacemaking in substantia nigra dopaminergic neurons. J. Neurosci. 29, 11011-11019. doi: 10.1523/JNEUROSCI.2519-09.2009
46. Guzman, J. N., Sanchez-Padilla, J., Wokosin, D., Kondapalli, J., Ilijic, E., Schu-macker, P. T., et al. (2010). Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 468, 696-700. doi: 10.1038/nature09536
47. Heeman, B., Van den Haute, C., Aelvoet, S. A., Valsecchi, F., Rodenburg, R. J., Reumers, V., et al. (2011). Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance. J. Cell Sci. 124, 1115-1125. doi: 10.1242/jcs.078303
48. Henchcliffe, C., and Beal, M. F. (2008). Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat. Clin. Pract. Neurol. 4, 600-609. doi: 10.1038/ncpneuro0924
49. Ito, H., Goto, S., Sakamoto, S., and Hirano, A. (1992). Calbindin-D28k in the basal ganglia of patients with parkinsonism. Ann. Neurol. 32, 543-550. doi: 10.1002/ana.410320410
50. Jenner, P. (2001). Parkinson's disease, pesticides and mitochondrial dysfunction. Trends Neurosci. 24, 245-247. doi: 10.1016/S0166-2236(00)01789-6
51. Kaufman, R. J., and Malhotra, J. D. (2014). Calcium trafficking integrates endoplas-mic reticulum function with mitochondrial bioenergetics. Biochim. Biophys. Acta doi: 10.1016/j.bbamcr.2014.03.022 [Epub ahead of print].
52. Keeney, P. M., Xie, J., Capaldi, R. A., and Bennett, J. P. Jr. (2006) Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J. Neurosci. 26, 5256-5264. doi: 10.1523/JNEUROSCI.0984-06.2006
53. Khaliq, Z. M., and Bean, B. P. (2010). Pacemaking in dopaminergic ventral tegmental area neurons: depolarizing drive from background and voltage-dependent sodium conductances. J. Neurosci. 30, 7401-7413. doi: 10.1523/JNEUROSCI.0143-10.2010
54. Kienzle, C., and von Blume, J. (2014). Secretory cargo sorting at the trans-Golgi network. Trends Cell Biol. doi: 10.1016/j.tcb.2014.04.007 [Epub ahead of print].
55. Kirichok, Y., Krapivinsky, G., and Clapham, D. E. (2004). The mitochondrial calcium uniporter is a highly selective ion channel. Nature 427, 360-364. doi: 10.1038/nature02246
56. Kish, S.J., Shannak, K., and Hornykiewicz, O. (1988). Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Patho-physiologic and clinical implications. N. Engl. J. Med. 318, 876-880. doi: 10.1056/NEJM198804073181402
57. Klempner, M. S. (1985). An adenosine triphosphate-dependent calcium uptake pump in human neutrophil lysosomes. J. Clin. Invest. 76, 303-310. doi: 10.1172/JCI111961
58. Kordower, J. H., and Bjorklund, A. (2013). Trophic factor gene therapy for Parkinson's disease. Mov. Disord. 28, 96-109. doi: 10.1002/mds.25344
59. Kraytsberg, Y., Kudryavtseva, E., McKee, A. C., Geula, C., Kowall, N. W., and Khrapko, K. (2006). Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat. Genet. 38, 518-520. doi: 10.1038/ng1778
60. LaFerla, F. M. (2002). Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev. Neurosci. 3, 862-872. doi: 10.1038/nrn960
61. Lee, I., Bender, E., Arnold, S., and Kadenbach, B. (2001). New control of mitochon-drial membrane potential and ROS formation-a hypothesis. Biol. Chem. 382, 1629-1636. doi: 10.1515/BC.2001.198
62. Lemons, R. M., and Thoene, J. G. (1991). Mediated calcium transport by isolated human fibroblast lysosomes. J. Biol. Chem. 266, 14378-14382.
63. 2+ storage in the Golgi. J. Cell Biol. 145, 279-289. doi: 10.1083/jcb.145.2.279
64. Lin, X., Parisiadou, L., Gu, X. L., Wang, L., Shim, H., Sun, L., et al. (2009). Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's disease-related mutant alpha-synuclein. Neuron 64, 807-827. doi: 10.1016/j.neuron.2009.11.006
65. Lin-Moshier, Y., Walseth, T. F., Churamani, D., Davidson, S. M., Slama, J. T., Hooper, R., et al. (2012). Photoaffinity labeling of nicotinic acid adenine dinucleotide phosphate (NAADP) targets in mammalian cells. J. Biol. Chem. 287, 2296-2307. doi: 10.1074/jbc.M111.305813
66. 2+ homeostasis of the trans-Golgi compartment. Proc. Natl. Acad. Sci. U.S.A. 107, 9188-9203. doi: 10.1073/pnas.1004702107
67. Lloyd-Evans, E., Morgan, A. J., He, X., Smith, D. A., Elliot-Smith, E., Sillence, D. J., et al. (2008) Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat. Med. 14, 1247-1255. doi: 10.1038/nm.1876
68. 2+ homeostasis: role in pathogenesis of lysosomal storage diseases. Cell Calcium 50, 200-205. doi: 10.1016/j.ceca.2011.03.010
69. 2+ and vacuolar H+-ATPases in human platelets. Biochem. J. 390, 243-252. doi: 10.1042/BJ20050168
70. Luzio, J. P., Bright, N. A., and Pryor, P. R. (2007). The role of calcium and other ions in sorting and delivery in the late endocytic pathway. Biochem. Soc. Trans. 35, 1088-1091. doi: 10.1042/BST0351088
71. Lynch-Day, M. A., Mao, K., Wang, K., Zhao, M., and Klionsky, D. J. (2012) The role of autophagy in Parkinson's disease. Cold Spring Harb. Perspect. Med. 2, a009357. doi: 10.1101/cshperspect.a009357
72. MacLeod, D., Dowman, J., Hammond, R., Leete, T., Inoue, K., and Abe-liovich, A. (2006). The familial Parkinsonism gene LRRK2 regulates neu-rite process morphology. Neuron 52, 587-593. doi: 10.1016/j.neuron.2006.10.008
73. Mann, V. M., Cooper, J. M., Daniel, S. E., Srai, K., Jenner, P., Marsden, C. D., et al. (1994). Complex I, iron, and ferritin in Parkinson's disease substantia nigra. Ann. Neurol. 36, 876-881. doi: 10.1002/ana.410360612
74. Manzoni, C., and Lewis, P. A. (2013). Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathies. FASEB J. 27, 3424-3429. doi: 10.1096/fj.12-223842
75. Marras, C., Gruneir, A., Rochon, P., Wang, X., Anderson, G., Brotchie, J., et al. (2012). Dihydropyridine calcium channel blockers and the progression of parkinsonism. Ann. Neurol. 71, 362-369. doi: 10.1002/ana.22616
76. Matzuk, M. M., and Saper, C. B. (1985). Preservation of hypothalamic dopaminergic neurons in Parkinson's disease. Ann. Neurol. 18, 552-555. doi: 10.1002/ana.410180507
77. 2+ in signal transduction in mammalian tissues. Biochim. Biophys. Acta 1018, 287-291. doi: 10.1016/0005-2728(90)90269-A
78. Micaroni, M. (2012). Calcium around the Golgi apparatus: implications for intracellular membrane trafficking. Adv. Exp. Med. Biol. 740, 439-460. doi: 10.1007/978-94-007-2888-2_18
79. Michel, P. P., Toulorge, D., Guerreiro, S., and Hirsch, E. C. (2013). Specific needs of dopamine neurons for stimulation in order to survive: implication for Parkinson disease. FASEB J. 27, 3414-3423. doi: 10.1096/fj.12-220418
80. Morikawa, H., Imani, F., Khodakhah, K., and Williams, J. T. (2000). Inositol 1,4,5-triphosphate-evoked responses in midbrain dopamine neurons. J. Neurosci. 20, RC103.
81. Mu, T. W., Fowler, D. M., and Kelly, J. W. (2008). Partial restoration of mutant enzyme homeostasis in three distinct lysosomal storage disease cell lines by altering calcium homeostasis. PLoS Biol. 6:e26. doi: 10.1371/journal.pbio.0060026
82. Nicholls, D. G. (2008). Oxidative stress and energy crises in neuronal dysfunction. Ann. N.Y. Acad. Sci. 1147, 53-60. doi: 10.1196/annals.1427.002
83. Orenstein, S. J., Kuo, S. H., Tasset, I., Arias, E., Koga, H., Fernandez-Carasa, I., et al. (2013). Interplay of LRRK2 with chaperone-mediated autophagy. Nat. Neurosci. 16, 394-406. doi: 10.1038/nn.3350
84. Papkovskaia, T. D., Chau, K. Y., Inesta-Vaquera, F., Papkovsky, D. B., Healy, D. G., Nishio, K., et al. (2012). G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization. Hum. Mol. Genet. 21, 4201-4213. doi: 10.1093/hmg/dds244
85. Paschen, W., and Mengesdorf, T. (2005). Endoplasmic reticulum stress response and neurodegeneration. Cell Calcium 38, 409-415. doi: 10.1016/j.ceca.2005.06.019
86. Pasternak, B., Svanstrom, H., Nielsen, N. M., Fugger, L., Melbye, M., and Hviid, A. (2012). Use of calcium channel blockers and Parkinson's disease. Am. J. Epidemiol. 175, 627-635. doi: 10.1093/aje/kwr362
87. 2+ signaling. Trends Cell Biol. 20, 277-286. doi: 10.1016/j.tcb.2010.02.003
88. Petersen, O. H., Michalak, M., and Verkhratsky, A. (2005). Calcium signalling: past, present and future. Cell Calcium 38, 161-169. doi: 10.1016/j.ceca.2005.06.023
89. 2+ transfer in the control of apoptosis. Oncogene 27, 6407-6418. doi: 10.1038/onc.2008.308
90. Pinton, P., Pozzan, T., and Rizzuto, R. (1998). The Golgi apparatus is an inositol 1,4,5-trisphosphate-sensitive Ca2+ store, with functional properties distinct from those of the endoplasmic reticulum. EMBO J. 17, 5298-5308. doi: 10.1093/emboj/17.18.5298
91. 2+ in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles. J. Cell Biol. 149, 1053-1062. doi: 10.1083/jcb.149.5.1053
92. Przedborski, S., Tieu, K., Perier, C., and Vila, M. (2004). MPTP as a mitochondrial neurotoxic model of Parkinson's disease. J. Bioenerg. Biomembr. 36, 375-379. doi: 10.1023/B:JOBB.0000041771.66775.d5
93. Puopolo, M., Raviola, E., and Bean, B. P. (2007). Roles of subthreshold calcium current and sodium current in spontaneous firing of mouse midbrain dopamine neurons. J. Neurosci. 27, 645-656. doi: 10.1523/JNEUROSCI.4341-06.2007
94. Ritz, B., Rhodes, S. L., Qian, L., Schernhammer, E., Olsen, J. H., and Friis, S. (2010). L-type calcium channel blockers and Parkinson disease in Denmark. Ann. Neurol. 67, 600-606. doi: 10.1002/ana.21937
95. 2+ pools in neuronal signalling. Curr. Opin. Neurobiol. 11, 306-311. doi: 10.1016/S0959-4388(00)00212-9
96. 2+: molecular determinants and functional consequences. Physiol. Rev. 86, 369-408. doi: 10.1152/physrev.00004.2005
97. Sanders, L. H., Laganiere, J., Cooper, O., Mak, S. K., Vu, B. J., Huang, Y. A., et al. (2014). LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: reversal by gene correction. Neurobiol. Dis. 62, 381-386. doi: 10.1016/j.nbd.2013.10.013
98. Santo-Domingo, J., and Demaurex, N. (2010). Calcium uptake mechanisms of mitochondria. Biochim. Biophys. Acta 1797, 907-912. doi: 10.1016/j.bbabio.2010.01.005
99. Scarffe, L. A., Stevens, D. A., Dawson, V. L., and Dawson, T. M. (2014). Parkin and PINK1: much more than mitophagy. Trends Neurosci. doi: 10.1016/j.tins.2014.03.004 [Epub ahead of print].
100. Schapira, A. H. (2008). Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol. 7, 97-109. doi: 10.1016/S1474-4422(07) 70327-7
101. 2+-binding protein localized to the Golgi lumen. J. Cell Biol. 133, 257-268. doi: 10.1083/jcb.133.2.257
102. Schultz, M. L., Tecedor, L., Chang, M., and Davidson, B. L. (2011). Clarifying lysoso-mal storage diseases. Trends Neurosci. 34, 401-410. doi: 10.1016/j.tins.2011.05.006
103. 2+ homeostasis in the Golgi and disturbs neural polarity. J. Neurosci. 29, 12174-12182. doi: 10.1523/JNEUROSCI.2014-09.2009
104. Stark, A. K., and Pakkenberg, B. (2004). Histological changes of the dopaminergic nigrostriatal system in aging. Cell Tissue Res. 318, 81-92. doi: 10.1007/s00441-004-0972-9
105. Sulzer, D. (2007). Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. Trends Neurosci. 30, 244-250. doi: 10.1016/j.tins.2007.03.009
106. Surmeier, D. J., Guzman, J. N., Sanchez-Padilla, J., and Goldberg, J. A. (2011). The origins of oxidant stress in Parkinson's disease and therapeutic strategies. Antioxid. Redox Signal. 14, 1289-1301. doi: 10.1089/ars.2010.3521
107. Surmeier, D. J., and Schumacker, P. T. (2013). Calcium, bioenergetics, and neu-ronal vulnerability in Parkinson's disease. J. Biol. Chem. 288, 10736-10741. doi: 10.1074/jbc.R112.410530
108. Thayer, D. A., Jan, Y. N., and Jan, L. Y. (2013). Increased neuronal activity fragments the Golgi complex. Proc. Natl. Acad. Sci. U.S.A. 110, 1482-1487. doi: 10.1073/pnas.1220978110
109. Tong, Y., Yamaguchi, H., Giaime, E., Boyle, S., Kopan, R., Kelleher, R. J. III, et al. (2010). Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice. Proc. Natl. Acad. Sci. U.S.A. 107, 9879-9884. doi: 10.1073/pnas.1004676107
110. Trinh, J., and Farrer, M. (2013). Advances in the genetics of Parkinson disease. Nat. Rev. Neurol. 9, 445-454. doi: 10.1038/nrneurol.2013.132
111. Verkhratsky, A. (2005). Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. Physiol. Rev. 85, 201-279. doi: 10.1152/physrev.00004.2004
112. Vila, M., Ramonet, D., and Perier, C. (2008). Mitochondrial alterations in Parkinson's disease: new clues. J. Neurochem. 107, 317-328. doi: 10.1111/j.1471-4159.2008.05604.x
113. 2+ ATPase SPCA1. Dev. Cell 20, 652-662. doi: 10.1016/j.devcel.2011.03.014
114. 2+-dependent secretory cargo sorting at the trans-Golgi network. J. Cell Biol. 199, 1057-1066. doi: 10.1083/jcb.201207180
115. Walseth, T. F., Lin-Moshier, Y., Jain, P., Ruas, M., and Parrington, J., (2012). Pho-toaffinity labeling of high affinity nicotinic acid adenine dinucleotide phosphate (NAADP)-binding proteins in sea urchin egg. J. Biol. Chem. 287, 2308-2315. doi: 10.1074/jbc.M111.306563
116. Wang, X., Zhang, X., Dong, X. P., Samie, M., Li, X., Cheng, X., et al. (2012). TPC proteins are phosphoinositide-activated sodium-selective ion channels in endosomes and lysosomes. Cell 151, 372-383. doi: 10.1016/j.cell.2012.08.036
117. Zhang, J., Perry, G., Smith, M. A., Robertson, D., Olson, S. J., Graham, D. G., et al. (1999) Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am. J. Pathol. 154, 1423-1429. doi: 10.1016/S0002-9440(10)65396-5